This group conducts and supports research on the prevention and early detection of colorectal, esophageal, liver, pancreatic, skin, and hematolymphoid cancers. Clinical trials and the evaluation of new agents, surrogate biomarkers, and new technologies to identify premalignant lesions are developed and supported.
This is a listing of Requests for Applications specific to the group's key programs.
Research focuses on prevention of colorectal, stomach, esophageal, and pancreatic cancer, and leukemia, lymphoma, myeloma, and sarcoma cancers.
This section contains a listing of journal articles and The Revised Bethesda Guidelines for Diagnostic Criteria for Hereditary Non-Polyposis Colorectal Cancer and Microsatellite Instability.
Mission, staff list, and contact information are in this section.
Back to top
